Showing results (1481-1490 of 1,557) with videos related to
Sort By:
Pageof 156
Cancer Cell|July 14, 2012
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastomaTeeara Berry, William Luther, Namrata Bhatnagar, et al.Biorxiv : the Preprint Server for Biology|April 1, 2025
A Bivalent Molecular Glue Linking Lysine Acetyltransferases to Oncogene-induced Cell DeathMeredith N Nix, Sai Gourisankar, Roman C Sarott, et al.Molecular Cell|July 5, 2017
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 RecruitmentGeorg E Winter, Andreas Mayer, Dennis L Buckley, et al.Journal of the National Cancer Institute|August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugsBakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.JCI Insight|February 1, 2022
Ferret models of alpha-1 antitrypsin deficiency develop lung and liver diseaseNan He, Xiaoming Liu, Amber R Vegter, et al.Cancer Research Communications|April 21, 2023
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1AManjunath Siddappa, Shahid Hussain, Sajad A Wani, et al.Cell|August 13, 2021
Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapyKazuhiro Koikawa, Shin Kibe, Futoshi Suizu, et al.Cancer Discovery|September 21, 2021
INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase InhibitorsQing Li, Baishan Jiang, Jiaye Guo, et al.Nature Communications|October 20, 2019
A kinase-independent role for CDK8 in BCR-ABL1+ leukemiaIngeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, et al.Cell Chemical Biology|June 8, 2023
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutationMatthew L Arwood, Yao Liu, Shannon K Harkins, et al.Pageof 156